First case of subcutaneous dematophytosis in a Tunisian renal transplant patient
##plugins.themes.academic_pro.article.main##
Abstract
Background: Dermatophytes are keratinophilic and usually infect the corneal layer of the epidermis and appendages On the occasion of immunosuppression, such as solid organ transplant, they can invade deeper tissues or cause an infection of the skin and subcutaneous disseminated.
Aim: To report the first observation of subcutaneous dematophytosis in a Tunisian renal transplant patient.
Case report: A 29-year-old man had an erythematous lesion of 2 cm at the front of the left leg. He was treated with prednisone and tacrolimus. The skin lesion was has been neglected. The outcome was the occurrence of oozing whose mycological examination showed numerous hyphae and culture was positive for Microsporum canis. Initial treatment was voriconazole, but an interaction with tacrolimus has shortened the duration of treatment to 1 month. Three months later, the lesion became deeper, and then a biopsy was performed. The mycological examination showed the same appearance, previously described. The patient was put on fluconazole by adjusting the doses of tacrolimus and then underwent surgical excision of the lesions. The evolution after 4 months of antifungal treatment was favorable.
Conclusion: The increasing incidence of immunosuppressive therapy has given rise to unusual clinical forms of invasive and sometimes serious fungal agents whose pathogenicity is usually limited. Clinicians should be mindful of superficial fungal infections of the skin in a renal transplant patient
Aim: To report the first observation of subcutaneous dematophytosis in a Tunisian renal transplant patient.
Case report: A 29-year-old man had an erythematous lesion of 2 cm at the front of the left leg. He was treated with prednisone and tacrolimus. The skin lesion was has been neglected. The outcome was the occurrence of oozing whose mycological examination showed numerous hyphae and culture was positive for Microsporum canis. Initial treatment was voriconazole, but an interaction with tacrolimus has shortened the duration of treatment to 1 month. Three months later, the lesion became deeper, and then a biopsy was performed. The mycological examination showed the same appearance, previously described. The patient was put on fluconazole by adjusting the doses of tacrolimus and then underwent surgical excision of the lesions. The evolution after 4 months of antifungal treatment was favorable.
Conclusion: The increasing incidence of immunosuppressive therapy has given rise to unusual clinical forms of invasive and sometimes serious fungal agents whose pathogenicity is usually limited. Clinicians should be mindful of superficial fungal infections of the skin in a renal transplant patient
Keywords:
Dermatophytosis subcutaneous, renal transplantation, Microsporum canis, treatment##plugins.themes.academic_pro.article.details##
References
- Peterson PK, Andersen RC. Infection in renal transplant recipients: Current approaches to diagnosis, therapy, and prevention. Am J Med 1986;81:2-10.
- Virgili A, Zampino MR, Mantovani L. Fungal Skin Infections in Organ Transplant Recipients. Am J Clin Dermatol 2002;3:19-35.
- Güleç AT, Demirbilek M, Seçkin D et al. Superficial fungal infections in 102 renal transplant recipients: a case-control study. J Am Acad Dermatol 2003;49: 187-92.
- Dicle O, Parmaksizoglu B, Gurkan A et al. Skin infections in 401 renal transplant recipients in southern Turkey. Exp Clin Transplant 2009;7:133-6
- Sentamil Selvi G, Kamalam A, Ajithados K, Janaki C, Thambiah AS. Clinical and mycological features of dermatophytosis in renal transplant recipients Mycoses. 1999;42:75-8.
- Deniz Seçkin, Sevtap Ar›kan, Mehmet Haberal. Deep dermatophytosis caused by Trichophyton rubrum with concomitant disseminated nocardiosis in a renal transplant recipient. J Am Acad Dermatol 2004;51:S173-S176
- Berg JC, Hamacher KL, Roberts GD. Pseudomycetoma caused by Microsporum canis in a immunosuppressed patient: a case report and review of the literature. J Cutan Pathol 2007;34:431-4.
- Chiapello LS, Dib MD, Nuncira CT, et al. Mycetoma of the scalp due to Microsporum canis: hystopathologi, mycologic and immunogenetic features in a 6-year-old girl. Diagn Microbiol Infect Dis 2011;70:145-9.
- Virgili A, Zampino MR. Relapsing tinea capitis by Microsporum canis in an adult female renal transplant recipient. Nephron 1998;80:61-2.
- Donnelly JP, De Pauw BE. Voriconazole-a new therapeutic agent with an extended spectrum of antifungal activity. Clin Microbiol Infect 2004;10:107-17.
- Delaunay P, Fissore C. Interactions médicamenteuses des antifongiques systémiques. J Mycol Med 2006;16:152-8.
- Arabatzis M, Kyprianou M, Velegraki A, Makri A, Voyatzi A. Microsporum canis antifungal susceptibilities: concerns regarding their clinical predictability. Int J Antimicrob Agents 2010;36:385-6.